Your browser doesn't support javascript.
loading
Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark - a region wide study.
Bollerup, Signe; Hallager, Sofie; Baek, Ole; Krarup, Henrik; Madsen, Lone Galmstrup; Thielsen, Peter; Balslev, Ulla; Mens, Helene; Barfod, Toke; Rye Clausen, Mette; Hobolth, Lise; Gerstoft, Jan; Weis, Nina.
Afiliação
  • Bollerup S; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
  • Hallager S; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
  • Baek O; Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre, Denmark.
  • Krarup H; Department of Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.
  • Madsen LG; Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark.
  • Thielsen P; Department of Medical Gastroenterology, Zealand University Hospital, Koege, Denmark.
  • Balslev U; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Mens H; Department of Gastroenterology, Herlev Hospital, Herlev, Denmark.
  • Barfod T; Department of Infectious Diseases, Herlev Hospital, Herlev, Denmark.
  • Rye Clausen M; Department of Lung- and Infectious Diseases, North Zealand Hospital, Hilleroed, Denmark.
  • Hobolth L; Department of Internal Medicine and Infectious Diseases, Zealand University Hospital, Roskilde, Denmark.
  • Gerstoft J; Department of Medical Gastroenterology and Hepatology, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Weis N; Department of Gastroenterology, Copenhagen University Hospital, Hvidovre, Denmark.
Scand J Gastroenterol ; 55(7): 843-847, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32568561
Objective: To evaluate implementation of national guideline recommendations on treatment initiation for chronic hepatitis B (CHB) in Denmark.Methods: Using DANHEP, a nationwide cohort of chronic hepatitis B and C patients attending specialized hospital care in Denmark, we performed a descriptive cohort study from January 2002 through December 2017. We identified patients with CHB in 3 of 5 Danish regions, with at least two hospital/outpatient clinic visits during the study period.Results: We identified 990 CHB patients who remained untreated throughout the study period, and 265 who initiated treatment. At their last visit 952/990 (96%, 95% CI 95-97) untreated patients did not meet current national criteria for treatment initiation while 198/265 (75%, 95% CI 69-80) who initiated treatment met the national criteria. Overall, 198/236 (84%, 95% CI 79-88) who met national treatment criteria, initiated treatment.Conclusion: The majority of CHB patients received care in line with national guideline recommendations for treatment initiation. We found that only few patients eligible for treatment remained untreated. However, a fourth of patients who received treatment were not eligible according to national guidelines.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite B Crônica / Fidelidade a Diretrizes Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Scand J Gastroenterol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Hepatite B Crônica / Fidelidade a Diretrizes Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Scand J Gastroenterol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Dinamarca